PDT Partners, LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$45,000
-81.2%
25,225
-69.5%
0.01%
-66.7%
Q2 2022$240,000
-46.9%
82,754
-49.5%
0.02%
-46.2%
Q1 2022$452,000
-39.0%
163,936
+3.1%
0.04%
-30.4%
Q4 2021$741,000
+243.1%
158,951
+525.3%
0.06%
+250.0%
Q3 2021$216,00025,4190.02%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders